RT Journal Article
SR Electronic
T1 A global survey on changes in the supply, price and use of illicit drugs and alcohol, and related complications during the 2020 COVID-19 pandemic
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.16.20155341
DO 10.1101/2020.07.16.20155341
A1 Ali Farhoudian
A1 Seyed Ramin Radfar
A1 Hossein Mohaddes Ardabili
A1 Parnian Rafei
A1 Mohsen Ebrahimi
A1 Arash Khojasteh Zonoozi
A1 Cornelis A J De Jong
A1 Mehrnoosh Vahidi
A1 Masud Yunesian
A1 Christos Kouimtsidis
A1 Shalini Arunogiri
A1 Helena Hansen
A1 Kathleen T Brady
A1 Marc N Potenza
A1 ISAM-PPIG Global Survey Consortium
A1 Alexander Mario Baldacchino
A1 Hamed Ekhtiari
YR 2020
UL http://medrxiv.org/content/early/2020/07/24/2020.07.16.20155341.abstract
AB Background and aims COVID-19 has infected more than 13 million people worldwide and impacted the lives of many more, with a particularly devastating impact on vulnerable populations, including people with substance use disorders (SUDs). Quarantines, travel bans, regulatory changes, social distancing and ‘lockdown’ measures have affected drug and alcohol supply chains and subsequently their availability, price and use patterns, with possible downstream effects on presentations of SUDs and demand for treatment. Given the lack of multicentric epidemiologic studies, we conducted a rapid global survey within the International Society of Addiction Medicine (ISAM) network in order to understand the status of substance-use patterns during the current pandemic.Design Cross-sectional survey.Setting Worldwide.Participants Starting on April 4th, 2020 during a 5-week period, the survey received 185 responses from 77 countries.Measurements To assess addiction medicine professionals’ perceived changes in drug and alcohol supply, price, use pattern and related complications during the COVID-19 pandemic.Findings Participants reported (among who answered “decreased” or “increased”, percentage of those who were in majority is reported in the parenthesis) a decrease in drug supply (69.0%), and at the same time an increase in price (95.3%) globally. With respect to changes in use patterns, an increase in alcohol (71.7%), cannabis (63.0%), prescription opioids (70.9%), and sedative/hypnotics (84.6%) use was reported while the use of amphetamines (59.7%), cocaine (67.5%), and opiates (58.2%) was reported to decrease overall.Conclusions The global report on changes in the availability, use patterns and complications of alcohol and drugs during the COVID-19 pandemic should be considered in making new policies and in developing mitigating measures and guidelines during the current pandemic (and probable future ones) in order to minimize risks to SUDs.Competing interest Authors claimed no competing interestCompeting Interest StatementThe authors have declared no competing interest.Clinical Protocols http://bcn.iums.ac.ir/browse.php?a_id=1821&sid=1&slc_lang=en&html=1 Funding StatementThe study has been conducted with no funds from external sources.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The proposal was submitted to the University of Social Welfare and Rehabilitation Sciences, Tehran, Iran and received the full approval of the ethics committee (Code: IR.USWR.REC.1399.061).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesSurvey data is available upon request